the following are appropriate:	
surveillance includes the following:	
growth	uberon
neurologic	
cardiac	
appropriate surveillance includes:	
appropriate surveillance includes the following:	
other	
musculoskeletal	
eyes	
ophthalmologic evaluation	
cardiovascular	
nutritional status	
no clinical guidelines for surveillance are available	
table 4	
evaluation	
skin	
respiratory	
hearing	
annual	
ophthalmologic examination	
liver function tests	
annual:	
gastrointestinal	
system	
routine	
dental	
eye	uberon
or x	
cbc	
pulmonary function tests	
surveillance should include annual neurologic examination	
blood pressure	
neurologic examination	
hearing loss	
regular follow up of ophthalmologic and/or audiologic abnormalities	
ecg	
the following should be performed on a regular basis:	
ophthalmologic assessment	
hearing evaluation	
complete blood count	
surveillance includes:	
annual hearing evaluation	
neurologic assessment	
children	
developmental progress	
1 year	
audiology evaluation	
x(until normal)	
skeletal assessment	
there are no published guidelines for surveillance	
annually	
plasma amino acids	
wilms tumor	
routine visits to the neurologist are appropriate	
rapid enlargement should prompt evaluation for possible hydrocephalus	
no evidence for the efficacy of regular neuroimaging exists	
skin should be examined at least annually	
assessments of respiratory function to detect asymptomatic decline	
inquire about frequency and severity of chest infections	
the eeg at 24 months should be normal	
there is no consensus on clinical surveillance	
may be repeated as needed)	
developmental and neurocognitive progress, as age-appropriate	
audiologic assessment	
eye examination	
periodic assessment of bleeding and clotting parameters by a hematologist	
follow up with an orthopedist when scoliosis becomes evident	
affected individuals	
measurement of blood pressure	
endocrine	
cognitive development	
ophthalmologic	
malignancy	
sleep studies	
brain mri	
pulmonary	
orthopedic	
repeat audiometry to confirm stability of hearing loss	
hepatic function	
developmental and neurologic assessment	
afp and hepatic sonography to monitor for hepatocellular carcinoma	
cancer surveillance	
pulmonary fibrosis	hp
table 2	
surveillance for individuals with the 7q11	
23 duplication syndrome	
test/measurement	
monitoring of respiratory function	
surveillance should be individualized based on symptoms and organs affected	
recommended surveillance for individuals with ethylmalonic encephalopathy	
frequency	hp
hepatic function should be monitored every six to 12 months	
recommended surveillance for individuals with fbxl4-related mtdna depletion syndrome	
ent/mouth	
skeletal	
assessment for the following:	
evaluation by an otolaryngologist for adenotonsillectomy	
3 mmol/l	
abdominal ultrasound examination	
echocardiogram	
nutritional assessment	
pulmonary function testing	
colon cancer	hp
renal	
urinary tract	
adapted from gersh et al [2011]	
contractures and/or scoliosis	
recommended surveillance for individuals with kcnk9 imprinting syndrome	
frequency/comment	
every 6 months until age 2 years, then annually	
at least annually	
see thyroid evaluation	
routine pediatric care	
psychomotor development	
biochemical investigations	
yearly, beginning at the specified age:	
pheochromocytoma	hp
men 2a	
fmtc	
men 2b	
urinalysis	
the following are recommended:	
clinical evaluations to characterize cchs phenotype based on phox2b variant	
x 2	
adapted from weese-mayer et al [2010]	
, 20/24	
nparm = non-polyalanine repeat expansion mutation (i	
exogenous and endogenous gas challenges	
comprehensive age-appropriate clinical autonomic testing	
exon or whole-gene deletion or duplication	
screening and surveillance guidelines for peutz-jeghers syndrome	
8, 18 1	
3 years 1	
monthly	
adapted from syngal et al [2015]	
mre = magnetic resonance enterography	
mrcp = magnetic resonance cholangiopancreatography	
ct enterography may be used as an alternative	
digital mammography if mri not available	
discuss prophylactic mastectomy	
discuss prophylactic hysterectomy and oophorectomy	
recommended surveillance for individuals with ptls	
dental evaluation	
a child psychologist can assess cognitive & behavioral issues	
recommended surveillance for individuals with pura-related neurodevelopmental disorders	
the frequency has not been well established	
biannual:	
occupational therapy and physical therapy assessments	
every four months until age four years	
annually after age seven years	
ongoing developmental assessments	
table 3	
afp = alpha-fetoprotein	
alt/ast = alanine transaminase/aspartate transaminase	
bun = blood urea nitrogen	
cbc = complete blood count	
ggt = gamma-glutamyl transferase	
pt/ptt = prothrombin time/partial thromboplastin time	
consultation with other specialists as applicable	
surveillance for williams syndrome	
renal and bladder ultrasound	
except as noted	
if normal, ogtt should be repeated every five years	
audiometry	
neuropsychological testing to establish functional level and learning capacities	
blood tests	
immunologic status, focusing on sle, is recommended	
bone densitometry every two to five years to assess osteopenia	
hbh disease	
screening evaluations are likely to underestimate cognitive abilities	
ophthalmologic examination is indicated:	
every two to three years in adults	
development	
head growth and risk for hydrocephalus	
craniocervical junction	
sleep apnea	hp
ears and hearing	
kyphosis	hp
legs	
spinal stenosis	
adaptation to difference	
surveillance should be individualized using a multidisciplinary approach	
individuals on ert also require periodic monitoring as follows:	
plasma levels of peg-ada activity	
erythrocyte daxp concentration	
monitoring for the appearance or recurrence of dermatofibrosarcoma protuberans	
ocular	
serial evaluation of eegs to monitor disease progression is appropriate	
in particular:	
dental findings over time may warrant use of dental prosthetics	
monitoring for signs of diabetes insipidus in the neonatal period	
monitoring of the spine for the development of scoliosis	
this should not be delayed unnecessarily	
if puberty does start spontaneously it is likely to arrest	
thus, careful monitoring of testosterone levels is needed	
routine dermatologic evaluation to monitor for vascular and other malignancies	
a few other countries have also initiated screening	
note: serum α-fetoprotein measurement is not helpful	
asymptomatic children at risk	
less frequent intervals may also be appropriate	
every 1-2 months in infants age ≤12 months	
every 3-4 months in children age ≤10 years	
urology	
ochronotic prostate stones appear on radiography	
primary care provider	
neurologist	
clinical geneticist	
hepatologist or gastroenterologist	
physiatrist	
psychiatrist	
ophthalmologist	
pulmonologist	
laboratory tests	
every three months	
urine analysis	
serum concentration of lactic acid	
biannually	
urine organic acids	
imaging and diagnostic procedures	
liver ultrasound examination annually	
eeg and video eeg monitoring (e	
, for suspicion of subclinical status epilepticus	
presence of epilepsia partialis continua	
audiogram and brain stem auditory evoked responses as clinically indicated	
barium swallow study as clinically indicated	
clinical, neurologic, and neuropsychological follow up is necessary	
specialized multidisciplinary als clinic evaluations are suggested every three months	
pt/ot evaluation	
speech evaluation	
rod-cone dystrophy	hp
obesity	hp
progressive sensorineural hearing loss	
audiometry should be performed yearly	
cardiomyopathy	hp
insulin resistance/type 2 diabetes	
hyperlipidemia	hp
renal disease	
hepatic disease	
pulmonary disease	
hypothyroidism	hp
patients should be monitored annually for thyroid abnormalities	
monthly surveillance to identify and manage secondary complications is indicated	
lifelong clinical follow up should include the following:	
renal function monitoring by measurement of: blood pressure	
body weight	
serum concentrations of creatinine, albumin, and cholesterol	
24-hour urinary protein	
and creatinine clearance	
agents/circumstances to avoid	
evaluation of relatives at risk	
pregnancy management	
standard measures for prevention of fetopathy should be followed	
these include:	
possible changes of medication prior to pregnancy	
appropriate measures include the following:	
annual clinical examination for scoliosis	
amblyopia and refractive error	
detection of later-onset eye pathology	
glaucoma	hp
measurement of intraocular pressure	
optic disc examination	
visual field assessment, when possible	
aniridic fibrosis syndrome	
see wilms tumor overview	
renal function	
for asymptomatic persons, evaluate less frequently	
routine visits to the attending neurologist are indicated	
periodic assessment of the following:	
bladder function	
gait	
sensation in the distal lower extremities	
cognition (e	
, executive function)	
there are no formal guidelines regarding surveillance	
the authors suggest obtaining the following:	
counsel patients regarding the signs of liver dysfunction	
no surveillance guidelines have been developed	
monitor kidney function	
facilitate medication compliance	
periodic evaluation of liver function tests may be necessary	
the appropriate frequency is unknown	
periodic evaluation of serum electrolytes is appropriate	
the frequency unknown	
pulmonary follow up	
increased vigilance for emphysema is appropriate	
, serial radiographs to evaluate for progression of scoliosis	
visual impairment appears to be progressive	
thus, regular evaluation by an ophthalmologist is recommended	
screening recommendations:	
ecg, annually or more frequently depending on symptoms	
echocardiogram, annually or more frequently depending on symptoms	
holter monitoring, event monitoring, implantable loop recorder	
exercise stress testing	
cardiac mri, with frequency depending on symptoms and findings	
periodic cbcs are warranted	
, every 6 months), especially in children	
ophthalmologic and audiologic examinations	
bone densitometry to assess for osteoporosis in the adult	
consensus management recommendations have not been established	
uveal melanoma	
malignant mesothelioma	hp
no reliable early disease symptoms or screening modalities	
cutaneous melanoma, basal cell carcinoma and atypical spitz tumors	
clear cell renal cell carcinoma	hp
early detection allows specific treatment of intraocular hypertension	
routine follow up of deafness for any evidence of progression	
screening for malignancies	
suggested surveillance is summarized here:	
routine (at least annual) measurement of blood pressure	
annual endocrinology review	
bethlem myopathy	
ullrich cmd	
once scoliosis is evident, regular orthopedic follow up	
clinical assessment of nutritional status	
kcnq2-bfne	
kcnq2-nee	
thorough neurologic and neuropsychiatric assessment is indicated annually	
renal tumor screening	
if any suspicious lesion (<1	
renal tumors less than 3	
0 cm in diameter are monitor by periodic imaging	
melanoma	hp
for all children with biotinidase deficiency:	
regularly scheduled appointments with primary care physicians or as needed	
monitor for changes related to the major findings over time	
otologic anomalies	
renal anomalies	
regular assessment of renal function to prevent progression to esrd	
follow-up ophthalmologic examination every one to two years	
women	
monthly breast self-examination	
annual mammogram beginning at age 30	
men	
annual clinical breast examination beginning at age 35	
annual prostate cancer screening beginning at age 45	
women and men	
periodic screening for glycosuria as a manifestation of diabetes mellitus	
yearly cardiac ultrasound and ekg	
yearly or biennial liver ultrasound examination to detect fatty infiltration	
monitoring for hypoglycemia, especially in the neonatal period	
otherwise, clinical examination alone was recommended	
developmental screening as part of routine childcare	
serum lactate and glucose	
blood gases	
liver parameters	
and urine organic acids	
there are no standard international surveillance guidelines for cadasil	
consultation of other medical specialists (e	
currently, no standard surveillance protocols exist	
evaluation may be less often thereafter	
monitoring for testicular abnormalities in males	
monitoring fertility and metabolic risks in adults	
fecundity and fertility	
weight	
lipid profile	
bone mineral density	
imaging studies	
neonatal/infantile canavan disease	
mild/juvenile canavan disease	
annual routine follow up is indicated	
pre-pubertal pediatric individuals	
echocardiogram (annually	
testicular ultrasound for boys	
post-pubertal pediatric and adult individuals	
testicular ultrasound (annually)	
thyroid ultrasound (baseline examination	
transabdominal ultrasound of the ovaries (baseline examination	
urinary free cortisol levels (annually)	
serum igf-1 levels (annually)	
adrenal computed tomography	
pituitary mri	
three-hour oral glucose tolerance test (ogtt)	
90-minute thyroid releasing hormone (trh) testing	
periodic monitoring of the following is recommended:	
respiratory function: spirometry	
cardiac function: 24-hour electrocardiography and echocardiography	
mobility and muscle function: physiatrist and physical therapist consultation	
clinical evaluation should include assessment of:	
growth including weight, linear growth, and head circumference	
feeding ability	
laboratory evaluation should include:	
complete blood count (cbc) to monitor for cytopenias	
routine evaluations should include:	
brain mri and/or eeg as clinically indicated	
annual evaluations including:	
at least annual physical examination for evidence of kyphosis/scoliosis	
children with ccd should be monitored for the following:	
orthopedic complications	
dental abnormalities	
upper-airway obstruction	
sinus and ear infections	
osteoporosis	hp
sleep studies especially when patients show signs of nocturnal hypoxia	
thus far, heart valve dysplasia has not required correction	
recommended monitoring for iron overload:	
thyroid panel	
annual gastrointestinal evaluation including monitoring of growth	
routine monitoring of existing cardiac or renal anomalies	
echocardiogram and electrocardiogram	
perform annually during childhood and less frequently in adulthood	
plasma carnitine concentration	
serum ck concentration and liver transaminases	
consider measuring during acute illnesses	
annual ophthalmologic examinations starting at age four years	
asymptomatic carriers	
, abnormalities in cbc)	
complete neurologic examination	
hearing screen	
whether this is related to ced is unknown	
the authors are unaware of any other similar cases	
monitor the following:	
note: individuals receiving transfusion therapy need closer monitoring	
hepatic function every six to twelve months	
monitor for signs of precocious puberty	
audiologic	
annual evaluation of hearing is recommended	
dermatologic	
periodic evaluation for scoliosis during young childhood is recommended	
cfeom is congenital and is believed to be non-progressive	
and lung function tests, including fev1 and fvc	
eeg approximately every third year	
frequent clinical and radiologic dental evaluations should be performed	
neurologic deficits	
neurologic examination including assessment of memory, personality changes	
psychiatric abnormalities	
assessment for signs including depression and suicidal ideation	
impaired respiratory function	
sensorineural hearing loss	
audiologic examination including speech discrimination testing	
no guidelines for surveillance of classic chs exist	
abdominal ultrasound examination to monitor for hepatosplenomegaly	
cbc to evaluate for cytopenias	
measurement of serum ferritin concentration	
soluble interleukin-2 receptor measurement	
skeletal dysplasia	hp
anemia	hp
immunodeficiency and infection	
surveillance includes monitoring for evidence of scoliosis and its progression	
, height, weight, and head circumference	
plasma citrulline concentration	
serum psti concentration	
aro	
the possible manifestations and complications of osteopetrosis require repeat investigations	
adoii	
periodic tests of hearing and vision	
monitoring of the spine for the development of progressive kyphoscoliosis	
routine surveillance of muscle strength and respiratory function is recommended	
symptoms of nighttime hypoventilation should be considered	
regular evaluations to determine:	
need for change in diet to control weight	
need to involve specialists to evaluate and treat potential complications	
trpv4-associated neuromuscular disorders	
ent consultation with laryngoscopy	
dynamic breathing chest x-ray	
hearing assessment	
trpv4-associated skeletal dysplasias	
annual assessment for the development of joint pain and scoliosis	
a child reaches school age	
surgical procedures involving general anesthesia	
scoliosis needs to be closely followed	
monitoring four times a year is recommended	
yearly reassessment for known potential complications (e	
, hypertension	
renal or hepatic dysfunction	
declining vision and hearing) is appropriate	
growth and weight gain should be monitored	
annual clinical evaluation is reasonable	
hypoglycemia	hp
however, studies are ongoing	
bone density	
six of 29 persons with the fgfr3 pathogenic variant p	
for patients undergoing treatment:	
perform neuropsychological assessment of cognitive functions and speech	
monitoring should include:	
in advanced disease (i	
chest ct for detection of coronary and other vascular calcification	
recommended annual surveillance includes the following:	
neurologic and neuropsychologic evaluation	
cholestanol plasma concentration	
echocardiography	
measurement of total body density (tbd)	
these visits should include the following:	
resting ecg	
holter monitoring	
echo and mri at least every two years	
observation should include the following:	
blood counts several times a year	
plasma magnesium and potassium should also be assessed	
adjustment of dosage may be required	
dmd	
bmd	
evaluations should continue at least every two years	
confinement to a wheelchair	
reduction in vital capacity below 80% predicted	
age 12 years	
manual and mechanically assisted cough techniques	
evaluation for surgical interventions as needed	
an asymptomatic person with a known pathogenic variant	
monitoring of seizure activity by regular neurologic examination and eeg	
monitoring of orthopedic complications including foot deformity and scoliosis	
annual audiologic assessment	
sequential audiologic examinations are essential to:	
document the stability or progression of the hearing loss	
surveillance should include the following:	
monitoring of height, weight, and bmi	
clinical screening for scoliosis until the age of skeletal maturity	
1, although screening intervals are not delineated	
the following are also appropriate:	
ongoing routine pediatric care	
73 m2 (ckd stage 3b)	
ent and audiology evaluations at least yearly	
regular speech and language evaluation to monitor language development	
annual examination by a physician familiar with hereditary hearing impairment	
for individuals with nonsyndromic bilateral congenital hearing loss:	
neonatal multisystem disease:	
isolated hepatic disease	
evidence of renal disease (proteinuria and aminoaciduria)	
the following are indicated:	
complete blood counts several times a year	
monitoring of blood pressure in individuals who are steroid dependent	
evaluation by an endocrinologist	
cancer surveillance includes the following:	
bone marrow failure	
individuals on androgen therapy for bone marrow failure	
perform liver ultrasound examination semiannually for adenomas	
annual cancer screening by an otolaryngologist	
annual gynecologic examination	
annual skin cancer screening by a dermatologist	
oral and dental surveillance	
schedule routine screening and dental hygiene visits every six months	
maintain good oral hygiene	
urinalysis for microalbuminuria	
ophthalmologic examination to screen for retinopathy	
, at least every six months)	
developmental assessment to identify any special educational needs is appropriate	
sensory impairment	hp
dementia	hp
perform annual routine clinical testing for dementia:	
observation of behavior	
perform annual audiogram	
frequent and serial monitoring is needed	
the schedule should be determined by the findings present	
treatments (e	
surveillance is individualized based on disease progression	
in those with cardiac malformations or conduction defects:	
in those with renal anomalies:	
the frequency depends on the clinical situation	
0 mg/dl	
periodic neurodevelopmental and/or developmental/behavioral assessments	
interval/age	
infancy	
every 3 years	
assessment of intellectual abilities & academic achievement	
adolescents/adults	
genetic counseling	
monitoring and guidance as needed for educational and behavior problems	
regular lifelong dietary evaluation to assure optimal nutritional status	
regular lifelong evaluations of the following:	
heart: based on the type of congenital anomaly	
surveillance for infection and proper wound healing is indicated	
radiographic surveillance by an orthopedist is appropriate	
more advanced and invasive cardiac assessment may be required	
routine examination for inguinal hernia and surgical referral as necessary	
vigilant observation of blood pressure	
evaluation/action	
assess growth and monitor for failure to thrive	
at each visit	
monitor for epileptic crisis	
modify therapy according to clinical presentation and eeg findings	
annual mra from head to pelvis	
regular examinations to address:	
respiratory function	
joint contractures and scoliosis	
development or management of epileptic seizures	
encroaching lesions and those causing symptoms may merit excision	
annual evaluation with a multidisciplinary team including an endocrinologist	
individuals receiving androgen therapy	
liver function tests every three to six months	
annual gynecologic assessment for genital lesions beginning at age 13	
suspicious genital tract lesions should be biopsied	
annual or more frequent renal function studies	
annual cardiology evaluation	
annual audiology evaluation	
biennial brain mri/mra	
assessment of ambulation, speech, and swallowing	
regular review of communication needs and environmental adaptations	
in individuals known to have fap	
colonoscopy, once polyps are detected	
spigelman staging criteria can help determine the frequency	
non-fundic gland polyps should be removed endoscopically	
thyroid cancer	
annual abdominal palpation for desmoids	
small-bowel polyps and cancer	
screening for hepatoblastoma	
efficacy in individuals with fap is unclear	
adrenal tumors	
in individuals who have undergone colectomy	
in individuals known to have attenuated fap	
colectomy	
in individuals known to have gapps	
no surveillance guidelines have been published	
table 6	
continued assessment of nutrition and growth	
regular neurologic evaluations & developmental assessments	
immunologic	
monitoring for foot deformities and scoliosis	
routine assessment of growth in children	
follow-up frequency depends on findings	
screening for sleep-disordered breathing with polysomnography	
periodic assessment of psychomotor development and behavior in children	
annual audiology evaluation for evidence of hearing loss in xlos	
regular dental evaluations for individuals with xlos and ls	
audiologic screening	
blood pressure measurement and assessment of renal function	
standard monitoring for renal anomalies	
vertebral anomalies can lead to progressive scoliosis	
orthopedic monitoring is therefore indicated	
met694val pathogenic variant	
papillomatosis	
regular examinations	
serum and csf folate concentrations	
serum and csf homocysteine concentrations	
routine care by a general pediatrician	
curefa	
org]	
the following are appropriate	
annual fasting blood sugar to monitor for diabetes mellitus	
there are no specific surveillance guidelines for fryns syndrome	
pain	hp
respiratory dysfunction	
no additional audiometry screening of asymptomatic individuals is necessary	
ophthalmologic disease	
annual dilated ophthalmoscopy in childhood is indicated	
routine management of hormone deficiencies	
chemotherapy and hematopoietic stem cell transplantation for acute myelogeneous leukemia	
, absolute neutrophil counts above 0	
5x109/l)	
monitoring of growth in children and pubertal development in adolescents	
biochemical profile including lipid profile	
monitoring for development of varicose veins, especially in adults	
monitoring for osteopenia/osteoporosis	
no specific guidelines address the issue of surveillance	
biochemical testing	
, during the introduction of a new food)	
values >78 mmol/mol creatinine are abnormal	
schedule for individuals with classic or clinical variant galactosemia	
biochemical genetics clinic visits	
every six months during the second year of life	
yearly thereafter	
metabolic dietician clinic visits	
ophthalmologic evaluations	
speech evaluations	
developmental evaluations	
evaluations for premature ovarian insufficiency (poi)	
evaluations for osteopenia	
5 mg/100 ml in red blood cells	
follow growth	
monitor developmental milestones	
propose supportive intervention as needed	
the following should be monitored in persons with gan:	
intellectual development/deterioration	
the frequency of the monitoring should depend on disease progression	
annual or more frequent evaluation is recommended	
parenchymal abnormalities can be identified as well	
screening for pulmonary hypertension	
assessment of disease severity	
annual multidisciplinary examination to assess:	
height	
joint range of motion by an orthopedist/physiotherapist	
trachea for evidence of stenosis and respiratory compromise	
liver size for evidence of hepatomegaly	
blood measurement of ketone concentration is the preferred method	
gm1 gangliosidosis	
assessment of quality of life by a physiotherapist	
yearly and before/after major medical events	
monitoring of hip joint stability re risk of hip dislocation	
seizures	hp
yearly evaluation by a neurologist	
mps ivb	
assessment of quality of life by a physiotherapist:	
yearly: track progress and optimize ambulation	
cervical spine instability	hp
neurologic examination every six months	
mri neutral position: whole spine every year	
these guidelines can be modified as appropriate	
polysomnography if any clinical suspicion exists	
slit lamp examination of cornea	
examination of the posterior segment	
evaluation every six months	
yearly audiogram	
thyroid studies annually	
reevaluation of immunologic status between age nine and 12 months	
annual complete blood count and differential	
repeat audiology evaluation in infancy and prior to school enrollment	
routine surveillance for the development of scoliosis	
ongoing pediatric care with regular immunizations	
monitoring for symptoms (e	
routine monitoring of cardiac abnormalities	
in severe cases, monitoring by a vascular surgeon	
developmental surveillance should be conducted in all affected children	
surveillance of the liver may include the following:	
when hepatic adenoma is detected	
any imaging performed for liver surveillance (e	
cardiovascular surveillance	
close follow up is indicated	
chest x-rays at regular intervals	
yearly or more frequently as indicated	
this may include assessment for scoliosis and bone densitometry	
regular nutritional and feeding assessment	
periodic echocardiography	
the following are appropriate annually:	
measurement of height and weight to monitor growth	
laboratory studies: lfts, ck, lipid profile	
echocardiogram to monitor for cardiomyopathy	
bone density measurements are recommended after growth is complete	
annual routine physical examination	
annual review of diet	
height and weight should be measured annually to monitor growth	
bone density determinations are recommended after growth is complete	
liver phk deficiency	
liver imaging	
follow-up echocardiogram	
no guidelines established	
muscle phk deficiency	
nutrition and swallowing should be monitored	
onset of seizures and need for antiepileptic therapy	
need for physical therapy to minimize contractures and maintain locomotion	
clinical hfe-hh	
this may be accompanied with measurement of alpha fetoprotein	
01 kpa [friedrich-rust et al 2008]	
biochemical hfe-hh	
non-expressing p	
cys282tyr homozygotes	
general health should be closely followed	
imaging allows:	
assessment of spleen size to indirectly follow ph	
visualization of bile duct abnormalities (e	
physical therapy assessment for muscle weakness or contractures	
blood test:	
complete blood count with differential	
gastric cancer	
several screening modalities have been tested:	
endoscopy	
endoscopy permits direct inspection and biopsy of suspicious areas	
the submucosal lesions are difficult to identify	
further research is needed to evaluate this possibility	
69 of 99 (70%) endoscopies were normal	
lobular breast cancer (lbc)	
lehman 2006	
schelfout, personal communication]	
annually:	
lipid profiles	
dental examination, x-ray, and cleaning	
complete ophthalmologic examination with special attention to possible exposure keratopathy	
reevaluation for cerebral avm	
childhood	
, pneumatocoeles) have formed	
the following are recommended annually after hct:	
neuropsychological evaluation	
uterus	uberon
caution: ultrasound examination alone is never sufficient	
liver function	
electrolytes	
calcium, magnesium, and phosphate concentrations	
and iron status	
trace metal supplements are provided as needed	
treatment may need to be discontinued if:	
white blood count <3	
5x10^9/l	
neutrophils <2	
0x10^9/l	
platelets <150x10^9/l	
toxicity of iron supplementation	
endometrial cancer	
ovarian cancer	
gastric and duodenal cancers	
distal small bowel	
other cancers	
complications should be promptly addressed with appropriate therapy	
vitamin b12 and folate levels should be monitored	
renal ultrasound should be performed annually	
pulmonary function testing should be performed annually in adults	
colitis	hp
colonoscopy is used to confirm the diagnosis	
uterine tumors have only been reported in adults	
surveillance can begin at reproductive age	
cardiology visit with echocardiogram	
pulmonary clinic visit with pulmonary function testing	
audiogram	
developmental assessment	
sleep study for obstructive sleep apnea	
ncv study for evidence of carpal tunnel syndrome	
head/neck mri to document ventricular size and cervicomedullary narrowing	
opening pressure on lumbar puncture	
orthopedic evaluation to monitor hip disease	
individuals with known ahus	
note: individuals with esrd usually do not relapse	
for relatives at risk for hcm	
because penetrance of diagnostic features (i	
age	
screening guideline	
<12 yrs	
optional unless any of the following are present:	
12-18 yrs	
repeat evaluation every 12-18 months	
>18-21 yrs	
competitive athlete in intense training program	
symptoms	
other clinical findings that suggest early lvh	
permanent weakness requires continuous medication, eg	
the value should be between 3	
0 and 3	
5 mmol/l	
annual monitoring of thyroid function is appropriate	
1 mmol/l) is relatively specific for fh	
during treatment, individuals of any age with:	
fh should have lipid levels monitored as recommended	
surveillance includes periodic:	
neurologic evaluation to identify neurologic complications	
social adjustment should be monitored	
monthly until age three to four months	
every three months between ages four months and one year	
every six months between ages one and three years	
annually after age three years	
ongoing evaluation by a pedodontist or dentist is appropriate	
routine monitoring:	
annual routine follow-up with the multidisciplinary team is recommended	
at periodic intervals:	
echocardiogram and ekg to monitor for evidence of cardiomyopathy	
pulmonary function studies	
monitoring of behavior and mental status	
in intervals between ane events neurologic function is stable	
repeat pituitary mri	
persons with acromegaly	
persons with hypogonadism	
follow established guidelines	
recommendations follow	
more data are needed to develop appropriate future guidelines	
adults	
baseline	
thereafter	
perform annual clinical assessment and pituitary function tests	
yearly beginning at age four years	
measure height and weight with calculation of height velocity	
document pubertal development, tanner stages	
perform pituitary function tests (as for adults)	
perform baseline pituitary mri at about age ten years	
degree of spasticity and related complications, including scoliosis	
periodic sleep studies	
neuropsychological and developmental evaluation and testing, as appropriate	
these symptoms may warrant additional screening	
if negative, screening should be repeated in three years	
population	
the following are recommended for individuals with ks:	
evaluation of developmental milestones at each well child visit	
referral for formal developmental evaluation if delays are identified	
annual monitoring of vision	
expectant monitoring for otitis media in children	
the following should be assessed annually:	
thyroid function	
cardiac function if malformations are present	
renal function if hydronephrosis or multiple renal cysts are present	
table 5	
evaluation of nutritional status & growth	
evaluation of feeding difficulties	
sleep study (if history of sleep disturbance)	
evaluate for scoliosis	
every 6 months until age 2 years	
bfne	
bfie	
the eeg at 36 months should be normal	
appropriate measures include:	
strength testing (annually)	
pulmonary function tests (annually in advanced cases)	
cardiac and renal/urologic abnormalities should be monitored as needed	
bone age determinations	
the following should be assessed at least annually:	
vision, hearing	
yearly audiometry and endocrinologic evaluation	
evaluation by a child neurologist at regular intervals is appropriate	
special attention should be paid to growth and nutritional status	
chronic diarrhea or failure to thrive could indicate malabsorption	
special attention should be paid to nutritional status	
chronic diarrhea or weight loss could indicate malabsorption	
both children and adults	
consensus on optimal screening protocols has not been published	
lbsl is very slowly progressive in most cases	
annual clinical evaluations suffice	
rarely, vision appears to improve beyond expectations	
in such cases, a repeat erg is indicated	
standard surveillance includes the following:	
routine history re signs and symptoms of seizures	
monitoring for orthopedic complications such as foot deformity and scoliosis	
frequency depends on the severity	
the following is recommended:	
the following is suggested:	
monitoring of the airway and vocal cords by an otolaryngologist	
no surveillance guidelines for lms have been published	
monitor plasma uric acid concentration and urinary excretion of oxypurines	
monitor affected individuals for early signs of self-injury	
no formal guidelines exist	
monitoring should include the following:	
fasting and postprandial blood ammonia concentrations	
urinary orotic acid excretion	
evaluation of renal function	
attention to early clinical signs of lung involvement	
serum concentrations of ldh and ferritin	
no specific guidelines have been proposed	
repeat imaging of:	
gastrointestinal tract	
cardiovascular system	uberon
regular pediatric care	
individuals with biallelic germline	
in europe:	
registration or institutional access required):	
pan colonoscopy beginning at age 18-20 years	
individuals heterozygous for a germline	
fibrous dysplasia	
endocrinopathies	
precocious puberty	hp
thyroid	chebi
see gonadal involvement management in boys	
growth hormone excess	hp
see growth hormone excess evaluation:	
all children should be monitored for growth acceleration	
fgf23-mediated phosphate wasting	
hypercortisolism	
routine biochemical surveillance is not indicated	
see gastrointestinal management (pdf)	
hemoglobin concentration	
serum concentrations of uric acid and creatinine	
measurement of serum uric acid concentration at least annually	
one individual with mls developed life-threatening rhabdomyolysis	
early-onset lama2 md	
annual measurement of fvc to allow trending of fvc	
at least annual evaluation of the spine by an orthopedist	
cardiac monitoring:	
late-onset lama2 md	
monitor for respiratory insufficiency with serial pulmonary function tests	
monitor to detect and treat seizures	
routine developmental assessments	
monitoring of specific identified medical issues	
periodic:	
renal structure/function	
periodic monitoring of renal function	
serum concentration of magnesium, potassium, uric acid	
mody5	
hgba1c annually	
routine monitoring through early childhood	
audiologic and ophthalmological evaluations on a regular basis	
ongoing pediatric care	
specialized neurologic care for individuals with epilepsy	
monitoring for spine deformities	
monitoring as needed of cardiac and renal/urologic abnormalities	
routine developmental and learning assessments	
monitoring of any specific medical issues that are identified	
continued assessment of:	
feeding and nutrition	
developmental milestones	
possible psychiatric manifestations	
3 microdeletion until disproven otherwise	
the following should be monitored from early childhood:	
onset and frequency of seizures and response to antiepileptic medications	
number and type of infections	
autistic-like features	
gastrointestinal symptoms	
men1 minimal surveillance program	
fasting serum gastrin concentration from age 20 years 2	
imaging	
every three to five years beginning at the specified age	
head mri from age five years 2	
abdominal ct or mri from age 20 years 2	
notes:	
serum concentration of prolactin from age five years	
mtc	
hypoparathyroidism	hp
parathyroid adenoma or hyperplasia	
electrocardiogram and/or echocardiogram yearly for early detection of cardiomyopathy	
pulmonary function tests for individuals with exertional or nocturnal dyspnea	
regular follow up with a child neurologist for seizure management	
monitoring of head circumference and stature using standard growth charts	
the following surveillance is appropriate:	
surveillance as appropriate for each individual is recommended	
annual ophthalmologic assessment should address possible ophthalmologic changes	
annual follow up with a generalist is appropriate	
plasma and urine mma levels	
serum acylcarnitines and free and total carnitine levels	
liver, kidney, and bone health	
bone marrow indices	
monitoring of respiratory function should include the following:	
lung function tests (fev1 and fvc)	
assessment of the need for intermittent or permanent ventilation	
growth should be assessed regularly	
regular neuromuscular evaluation to assess disease progress is indicated	
breath test to screen for bacterial overgrowth is recommended	
annual assessment of joints by a rheumatologist or orthopedic surgeon	
additional recommendations include:	
repeat electrocardiogram and echocardiogram if symptoms of cardiac insufficiency occur	
however, recommended surveillance includes the following:	
brain mri to detect hydrocephalus and/or cerebellar tonsillar ectopia	
cardiac assessment including annual echocardiogram	
developmental assessment in all patients	
individuals on ert	
physical and neurologic evaluation at least every six months	
all individuals	
optimize ambulation	
pain severity assessment every six months	
age-appropriate quality of life questionnaires every year	
upper and lower extremities	
, functional dexterity test) of the upper extremities	
spine	
, extremity weakness	
clumsiness	hp
unsteady, changing gait	
evaluate heart rate annually	
polysomnography every three years	
monitor for vision and ocular abnormalities at every visit	
refer to an ophthalmologist as needed	
evaluate every six to 12 months	
perform yearly audiogram	
serum alpha fetoprotein (afp) concentration	
developmental evaluation	
urinalysis and urine amino acids to assess for renal tubulopathy	
the following assessments are indicated:	
, palmoplantar keratosis)	
annual ophthalmologic examination is recommended	
annual ophthalmologic exams for ophthalmoplegia, ptosis, and myopia	
potential screening tests include the following:	
annual blood counts [herman et al 1999]	
regular developmental assessments of affected children	
periodic repeat audiograms	
periodic assessment for strabismus	
monitoring for the development of otitis media (om)	
regular developmental assessments to plan and refine educational interventions	
every six months	
every year	
measurement of serum concentration of creatinine	
every three years	
audiometric evaluation	
measurement of serum ast, alt and ggt	
evaluation for upper airway stenosis (e	
annual ophthalmologic and audiology evaluations	
monitoring of physical skill development and joint mobility	
gagnon et al [2010] provide guidelines for surveillance	
annual ecg to detect asymptomatic cardiac conduction defects	
ophthalmologic examination every two years to evaluate for cataract formation	
annual measurement of the following is appropriate:	
urine albumin:creatinine ratio on a first-morning urine	
dental examination is indicated at least every six months	
neurologic, ophthalmologic, and cardiologic evaluations are recommended	
assessment of ambulation and speech abilities	
this may include clinical surveillance for the following:	
swallowing difficulties and recurrent aspiration	
x-ray surveillance of hip joints and spine	
monitoring of growth and development in infants and children	
routine assessment for scoliosis and joint contractures	
evaluations are recommended at least annually	
monitoring of blood pressure, growth parameters, and development	
urinalysis to monitor proteinuria	
regular developmental assessment by screening questionnaire (in childhood)	
regular blood pressure monitoring	
other studies (e	
it is not clear if earlier surveillance (i	
breast self-examination and ultrasonographic evaluation recommended in affected females	
carriers (heterozygotes)	
parents	
at-risk sibs	
severely affected individuals should be monitored for scoliosis	
observation for clinical evidence of venous stasis or ulcer disease	
nutrition status	
occupational and physical therapy needs	
fatigue	hp
bleeding, shortness of breath	
abdominal pain	hp
headaches	
extremity pain	
physical examination including assessment of neurologic function	
pulmonary function testing and chest radiograph	
nutrition assessment	
sleep disturbances are common in npc	
child syndrome	
ck syndrome	
neurologic surveillance of seizures for readjustment of medications if necessary	
orthopedic surveillance for scoliosis/kyphosis	
phox2b variant	
annual in-hospital comprehensive testing 1	
annual neurocognitive assessment	
annual 72-hr holter and ecg	
hirschsprung disease assessment	
tumors of neural crest origin assessment	
parm genotype:20/24, 20/25	
parm genotype: 20/26, 20/27	
parm genotype: 20/2820/33	
nparm	
x 3	
deletion/ duplication 4	
clinical evaluation for development of orthopedic manifestations (e	
cardiac follow-up for those with cardiac defects	
bleeding disorder	
for menstruating females:	
cardiac fibrosis	
ghosh et al 2013	
author, personal observation]	
no disease-specific guidelines have been developed	
follow up by an ophthalmologist to monitor vision	
audiometric evaluation with periodic follow up	
sdhc, sdhd,	
monitoring includes the following:	
in persons with sdhb pathogenic variants, periodic (e	
hearing should be evaluated annually	
annual ophthalmologic evaluation is indicated	
visual field testing is much more helpful	
coagulation factors and other synthetic liver functions should be monitored	
persons with overt hepatic dysfunction require more routine monitoring	
the use of routine neuroimaging is uncertain	
individuals with peroxisomal disorders may develop a progressive leukodystrophy	
monitor lactate levels regularly	
regular assessments of intellectual function should be offered	
semiannual or annual examination by an endocrinologist familiar with pds	
regular developmental assessments	
the patient's individual diagnosis and status	
surveillance would follow the	
guidelines for ipf [raghu et	
al 2011] or the specific type of iip	
those who are stable may be	
pulmonary function studies including the following to serially monitor	
disease course [raghu	
et al 2011]:	
forced vital capacity (fvc)	
saturation change at baseline	
monitoring for progression of disease by hrct of the chest	
oxygen saturation by resting pulse oximetry	
suspected of an underlying possibility for ctd-related ild	
monitoring for any side effects known from pharmacologic treatments	
symptom control	
periodic monitoring for fat-soluble vitamin deficiency is recommended	
preserved renal function (i	
ongoing urinalysis (spot and 24-hour collections)	
gfr <60 ml/min/1	
gfr <30 ml/min/1	
thyroid function testing	
electrocardiogram to evaluate for an associated atrioventricular block	
frequency of testing depends on the center	
quarterly	
six monthly to annually	
24 hour urine oxalate and supersaturation study	
during childhood:	
annual screening for developmental delay or learning disorders	
current suggested screening by age follows:	
cowden syndrome	
pediatric (age <18 years)	
yearly skin check with physical examination	
adult	
yearly thyroid ultrasound** and dermatologic evaluation	
women beginning at age 30 years:	
monthly breast self-examination**	
yearly breast screening (at minimum mammogram)	
mri may also be incorporated	
yearly transvaginal ultrasound or endometrial biopsy**	
for men and women:	
colonoscopy beginning at age 35 years**	
frequency dependent on degree of polyposis identified	
bannayan-riley-ruvalcaba syndrome	
screening recommendations have not been established for brrs	
proteus syndrome/proteus-like syndrome	
mcap syndrome	
a medical history with attention to:	
childhood cancer	
breathing or sleep problems	
a detailed neurologic evaluation	
renal ultrasound	
cloves syndrome	
therefore, diligent surgical care and monitoring are recommended	
fibroadipose hyperplasia	
site	
procedure	
age at initial screening (yrs)	
interval	
stomach	uberon
upper endoscopy	
small intestine	uberon
capsule endoscopy or mre 2	
8, 18 3	
3 years	
large intestine	uberon
colonoscopy	
breast	uberon
breast self-examination	
clinical breast exam	
6 months	
breast mri or digital mammography 4, 5, 6	
ovary, cervix, uterus	
transvaginal ultrasound & serum ca 125	
pelvic exam w/pap smear 6	
18-20	
pancreas	uberon
mri-mrcp or endoscopic ultrasound	
1-2 years	
testes	
testicular exam	
ultrasound if symptomatic or abnormality on exam	
birth to teenage years	
oral assessment for consequences of trauma	
swallowing evaluation and regular dietary assessments to assure adequate nutrition	
early detection of hypertension	
renal cell carcinoma	hp
intracranial aneurysms	
aortic dissection	hp
cardiac valvular abnormalities	
colon diverticulosis	
mineral balance, monitored by assessing calcium and phosphorous	
hydration status	
agents to avoid	
the following should be avoided:	
for affected individuals with hypertension, sympathomimetic agents	
potentially hepatotoxic agents (e	
no long-term sequelae are associated with pnkd	
monitoring medication requirements and dosage is appropriate	
no general surveillance guidelines have been developed to date	
monitoring should be individualized	
surveillance is usually performed annually	
comments	
at every visit	
ophthalmology evaluation	
yearly	
ent / mouth	
newborn hearing screen, then as indicated for speech delay	
every 6 months starting in early childhood	
echocardiogram w/attention to aortic root dimension & ecg	
every 3 yrs, if initial evaluations were normal	
otherwise, as directed by cardiologist	
monitoring for development of scoliosis	
clinical examination at every visit	
scoliosis survey if scoliosis is clinically suspected	
referral to orthopedist if indicated	
psychiatric	
behavioral assessment	
screen for behavior problems at every visit	
miscellaneous / other	
developmental monitoring by a developmental specialist	
annually, or at frequency directed by developmental specialist	
for short stature: consider endocrinology evaluation	
ppb	
thyroid gland neoplasia	
thyroid physical examination in a patient of any age	
ovarian stromal tumors	
cbme	
visual inspection of the eye and orbit	
botryoid erms	
ncmh	
nasal endoscopy as warranted by ophthalmologic signs (e	
pituitary blastoma	
pineoblastoma	hp
no specific guidelines for surveillance have been published	
recommendations include the following:	
abdominal ultrasound examination to assess liver and spleen size	
follow up as recommended by a pulmonologist and immunologist	
growth should be carefully monitored	
clinical evaluation should include assessment of the following:	
interval assessment for the need of g-tube	
neurologic evaluation including survey for seizures and movement disorders	
interval ophthalmologic evaluation including dilated eye examination	
evaluation for clinical signs of cardiomyopathy (e	
laboratory evaluation should include the following:	
complete blood count and differential to monitor for cytopenias	
renal function tests	
amylase and lipase as needed to evaluate for pancreatitis	
other evaluations:	
dexa scan	
brain mri, mrs, and eeg as clinically indicated	
plasma xanthine is cleared efficiently and does not accumulate	
symptomatic lower limb malalignment	
evidence of kyphoscoliosis	
symptoms related to joint hypermobility	
(see prevention of primary manifestations	
affected system	
cognitive	
monitoring by developmental pediatrics	
long-term	
eeg & video eeg monitoring	
if seizures are suspected	
ophthalmologic & vision evaluations	
monitoring for dysphagia & constipation	
monitoring for musculoskeletal complications including hip dysplasia & scoliosis	
every month in infancy	
every six months in the first decade of life	
at least annually thereafter	
cryptorchidism can recur after orchidopexy	
therefore, testicular position should be monitored	
obtain history of any sleep disturbance	
if present, obtain a sleep study	
obtain history for behavioral and psychiatric disturbance at least annually	
regular examination by an ophthalmologist with expertise in retinal disease	
regular physical examination with specific attention to the cardiovascular system	
monitoring by the affected individual for black tarry stool	
periodic monitoring of serum lipid concentrations	
psychiatric symptoms	
annual screening for developmental delays or learning disorders	
annual cardiac examination to identify cardiomyopathy and concomitant arrhythmias	
detection of subsequent rb after initial diagnosis	
detection of second non-ocular tumors in individuals with retinoblastoma	
older children and adults need less frequent monitoring	
periodic ecg to screen for prolonged qtc	
examination at regular intervals for the progression of scoliosis	
general examination	
discussion of any problems with riboflavin supplementation	
alkaline phosphatase level	
intact parathyroid hormone level	
renal ultrasound examination to assess for nephrocalcinosis	
the following evaluations should be considered:	
regular assessments of neurodevelopment, speech, and language	
rrm2b-related mitochondrial dna depletion syndrome and mitochondrial neurogastrointestinal encephalopathy	
rrm2b-related multiple mtdna deletions with external ophthalmoplegia	
care will be directed by clinical findings	
the following general evaluations are recommended:	
ecg advised biannually (kss phenotype)	
monitoring of growth with special attention to growth velocity	
close monitoring of speech and language development	
annual follow-up evaluation for ophthalmologic abnormalities	
yearly audiologic screens	
monitoring as per routine for cardiac or renal anomalies	
regular dental and orthodontic follow up	
annual evaluation by a physician familiar with rts	
monitoring of growth	
doses should be altered as needed	
monitor as follows:	
complete blood count annually	
annual evaluation of gait, coordination, and speech	
small children	
neurophysiologic studies when clinically indicated	
brain mri every three to five years	
adolescents and adults	
neurologic examination annually	
audiologic and ophthalmologic examinations every one to two years	
eeg and brain mri at least during status epilepticus	
neurologic evaluation every three to six months is appropriate	
gait, coordination, and speech should be evaluated annually	
periodic speech assessment if dysphagia becomes a problem	
monitoring of speech and swallowing difficulties is recommended	
surveillance of speech and ambulation	
driving ability should be assessed by professionals periodically	
routine visits to a neurologist are appropriate	
monitor with eeg and other modalities (e	
, headache, reduced school performance) are identified	
audiologic screening throughout childhood is indicated	
screen for sleep-disordered breathing at all visits	
note: discussions to update and maintain recommendations are ongoing	
for males with sgbs1:	
monitoring for hypoglycemia in the newborn period	
radiographs as needed	
monitoring of renal function if renal anomalies are present	
every three months until age four years	
every four months from age four to seven years	
biannually after age seven years	
the following screening recommendations require further study to determine benefit	
gonadoblastoma or hepatocellular carcinoma	
every six months between ages four and seven years	
neuroblastoma	hp
every six months from age four to seven years	
periodic hearing assessments in childhood	
the following are general guidelines compiled from several sources	
see published guidelines/consensus statements	
comprehensive medical and social evaluation	
routine dental care is recommended	
mental health and neurocognitive assessment	
annual laboratory assessment should include the following:	
cbc with differential and reticulocyte count	
assessment of iron status	
ldh as a marker of hemolysis	
vitamin d level	
assessment of stroke risk	
end-organ evaluation	
chest x-ray examination	
pulmonary function tests (pfts)	
six-minute walk test	
sleep study (to assess nighttime hypoxemia)	
iron overload by mri	
regular monitoring of the hips	
annual monitoring of renal, immune, and hematologic status	
routine monitoring of:	
height and weight using age and gender appropriate growth charts	
swallowing and diet to assure adequate nutrition	
ambulation and speech	
regular swallowing assessment to evaluate risk for aspiration	
, a clinical geneticist)	
affected children frequently die in infancy or early childhood	
the following are indicated on a routine basis:	
monitoring for scoliosis and kyphosis	
individuals with sma are evaluated at least every six months	
weaker children are evaluated more frequently	
recommended annually:	
thyroid function, including free t4 and tsh	
fasting lipid profile	
routine urinalysis to evaluate for occult urinary tract infections	
monitoring for scoliosis	
annually from infancy onwards for the following:	
assessment for increased intracranial pressure and medullary compression	
neurologic and otologic examination for consequences of cranial nerve entrapment	
the following are appropriate at the clinical evaluation:	
thorough history to identify known clinical sequelae of sotos syndrome	
cardiac auscultation	
blood pressure measurement	
examination for curvature of the spine	
urine dipstick to assess for quiescent urine infection	
referral to the appropriate clinical specialist if problems are identified	
note: cancer screening is not recommended	
the following measures are suggested:	
annual hearing test	
neurodevelopmental assessment annually for the first five years of life	
regular electrophysiologic investigations (e	
cognitive testing	
repeat skeletal survey	
, contractures)	
regular neurologic and developmental assessments are indicated	
annual examination by a vitreoretinal specialist is appropriate	
more advanced testing (e	
neuropsychological assessment	
eeg	
routine developmental and neurologic assessment	
periodic nutritional and growth assessment	
periodic hearing evaluation	
periodic ophthalmologic examination	
nutritional and growth assessment	
routine nutritional assessment is appropriate	
routine screening for depression at clinic visits is appropriate	
yearly dental evaluation is appropriate	
annual hearing evaluation is indicated	
routine assessment of neurologic status on physical examination	
audiology assessment	
eeg for seizure activity	
regular orthopedic evaluations to monitor scoliosis or joint problems	
soon after diagnosis is established:	
for trps i and trps ii	
monitor linear growth in childhood	
routine developmental assessments in childhood	
for trps ii only	
regular dietary evaluation in infancy to ensure optimal nutritional status	
monitoring of developmental progress and educational needs	
monitoring for spine deformities beginning in early childhood	
regular evaluation of teeth	
frequency determined by a dentist based on dental condition	
hematologic tests (cbc, reticulocyte count)	
hearing test	
cardiac evaluation	
neurologic evaluation	
at least yearly:	
medical evaluation including physical examination to assess weight and medications	
evaluation by orthopedists to assess for scoliosis and joint dislocation	
annual neurologic evaluation to assess symptoms and any emerging complications	
central nervous system	uberon
perform screening for tand features at least annually	
perform detailed clinical dermatologic inspection/exam annually	
initiation of therapy (baseline)	
first 6 months:	
after 6 months of rx: every 6-12 months	
after 2 years of rx: every 6-12 months	
as clinically indicated	
every 3 months	
tyrosinemia type i markers	
plasma concentration of methionine, phenylalanine, tyrosine	
blood / urine succinylacetone	
x(urine)	
blood nitisinone concentration	
hemoglobin, hematocrit, wbc, platelet count	
liver evaluation	
serum afp concentration	
pt/ptt	
bilirubin	chebi|uberon
alt/ast/ggt	
alkaline phosphatase	
ct or mri 1	
renal studies	
bun / creatinine	
urine: po4, ca, prot/cr ratio	
skeletal evaluation	
x-ray of wrist (for rickets)	
annual evaluation with the following specialists is appropriate:	
pediatrician for growth assessment	
neurologist to identify and manage seizures	
orthopedist for evaluation of contractures and back examination for scoliosis	
ophthalmologist for ocular manifestations and corrective therapy if needed	
annual blood pressure monitoring starting at age one year	
monitoring for complications is as follows:	
cns lesions	
visceral lesions	
annual abdominal ultrasound	
retinal angiomas	
endolymphatic sac tumors (elst)	
the best way to detect elst is unknown	
other guidelines originate from denmark and the netherlands	
two recent studies evaluated tumor progression	
measurement of immunoglobulin concentrations prior to ivig infusions	
broncho-alveolar lavage to diagnose pneumocystis jirovecii infection	
viral cultures or lung function studies as needed	
cerebrospinal imaging to diagnose leukodystrophy when clinically indicated	
click here for full text	
neonatal period and infancy	
otolaryngologic evaluation	
audiologic evaluation	
assessment of prelinguistic speech-language development	
longitudinal evaluation and treatment	
evaluations should be carried out routinely through adolescence	
routine dental evaluation should continue throughout life	
these evaluations should continue throughout adolescence	
annual ophthalmologic examination by a vitreoretinal specialist is indicated	
screening for type 2 diabetes mellitus at least annually	
annual lipid profile	
annual ophthalmologic examination for cataracts	
wolfram syndrome	
diabetes mellitus: tests of glucose tolerance	
optic atrophy: ophthalmologic examination	
sensorineural hearing loss: audiologic examination including speech discrimination testing	
diabetes insipidus: assessment of concentrating ability of the urine	
hypogonadism	hp
puberty: monitoring for signs of onset of puberty	
diabetic retinopathy	
microalbuminuria	hp
low-frequency sensorineural hearing loss (lfsnhl)	
regular audiologic examination including speech discrimination testing is appropriate	
complete blood count annually to evaluate for hematopoietic dysfunction	
and creatinine clearance test	
consideration of routine liver ultrasonography to evaluate for liver adenomas	
interval / age	
in infants – toddlers	
annual / all ages 1	
every 2 years	
serum concentration of calciumthyroid function and tsh level	
every 10 years	
in adults	
thyroid function test yearly until age 3 years	
medical evaluation	
vision screening to monitor for refractive errors and strabismus	
monitoring of blood pressure in both arms	
serum concentration of calcium	
thyroid function and tsh level	
evaluation for cataracts	
the hearing loss in ws1 is typically non-progressive	
hence, repeat audiogram would usually not be necessary	
monitor for endocrine abnormalities:	
hypogonadism at age 12-14 years	
diabetes mellitus in the teens and later	
hypothyroidism in the teens and later	
dystonia may require monitoring by a neurologist	
monitor hearing annually	
regular follow-up of ophthalmologic abnormalities	
ongoing follow-up with dermatologist	
routine monitoring of any existing cardiac and/or renal abnormalities	
regular hearing evaluations	
no formal surveillance guidelines exist	
the following are general considerations:	
at least once a year:	
chest x-rays or cts and sinus films	
monitor and treat pulmonary complications:	
bronchoscopic evaluations as indicated	
perform annual endoscopic evaluation	
at routine visits, monitor for the following:	
chronic neutropenia	
chronic diarrhea and resulting malnutrition	
if present, screen for ova and parasites	
autoimmune disorders with history, physical examination, and cbc	
(syndrome-specific growth charts are not available	
developmental progress should be monitored throughout infancy and childhood	
periodic audiograms	
the following routine monitoring is recommended:	
assessment of developmental progress and cognitive abilities	
screening for behavioral and psychiatric problems	
monitoring during testosterone replacement therapy should include the following:	
such testing should then be performed annually	
ongoing psychosocial support	
complete blood counts	
liver and renal function	
immune status	
donor and recipient chimerism	
